|Articles|February 1, 2004

Levalbuterol reduces hospitalizations for asthma from the ED

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Latest CME

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Is TNF-Like Ligand 1A (TL1A) Inhibition the Answer to Improving Disease Remission in Inflammatory Bowel Disease?

Jordan Axelrad, MD, MPH, FACG, FCCF; Jessica R. Allegretti, MD, MPH; Florian Rieder, MD

Trending on Contemporary Pediatrics

PCOS to PMOS: A long-awaited change

AAP expands RSV immunization recommendations for high-risk children

From primary care to specialist: Managing PMOS and insulin resistance

Diagnosing PMOS in adolescents: Criteria, ultrasound limits, and red flags

Can you guess the diagnosis of this 17-year-old male with loss of consciousness during a febrile illness?